Capital Raise


Halo Collective Enters into Unsecured Loan for up to $14 Million

January 6th, 2022 - Ryan Allway

TORONTO, Jan. 6, 2022 /CNW/ – Halo Collective Inc. (“Halo” or the “Company“) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced that it has entered into a loan agreement (the “Loan Agreement“) with Global Tech Opportunities 6 (the “Lender“), pursuant to which the Lender will loan up to $14,000,000 (the “Loan Amount“) to Halo in two tranches of $7,000,000 each, subject […]

PharmaCielo Completes Initial Tranche of Non-Brokered Private Placement of Debenture Units

December 31st, 2021 - Ryan Allway

TORONTO and RIONEGRO, Colombia, Dec. 31, 2021 /CNW/ – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. (“Holdings”), is pleased to announce that it has closed the first tranches of its previously announced non-brokered private placement (the “Offering”), consisting of an aggregate of 5,000 […]

Aleafia Health Announces Closing of a New $19 Million Credit Facility and Extension of Existing Credit Facility

December 29th, 2021 - Ryan Allway

Credit Facility provides the Company with liquidity to fund operations and organic growth initiatives Two-year term provides additional financial flexibility   TORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the closing of a credit facility of up to $19 million […]

Bespoke Financial Raises $125 Million to Expand Lending Capacity, Fund the Growth of the Cannabis Industry

December 1st, 2021 - Ryan Allway

Additional capital will fuel rapid growth as demand for debt financing accelerates   LOS ANGELES, Dec. 01, 2021 (GLOBE NEWSWIRE) — Bespoke Financial, the nation’s first cannabis-focused fintech lending platform, announced today the closing of a $125 million credit facility.   This infusion of capital from institutional investment funds is a strong show of confidence in […]

Eve & Co Announces Closing of Private Placement

September 29th, 2021 - Ryan Allway

STRATHROY, Ontario, Sept. 29, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSXV: EVE; OTCQX: EEVVF) is pleased to announce the closing of a private placement of 2,777,778 units (the “Units”) of the Company at a price of $0.18 per Unit for gross proceeds of $500,000 (the “Private Placement”). […]

Skye Bioscience Announces $7.0 Million Registered Direct Offering

September 27th, 2021 - Ryan Allway

SAN DIEGO, CA, Sept. 27, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, today announced that it has entered into securities purchase agreements with several institutional investors, for the purchase and sale […]

Australis Retains Delmorgan in $15M Capital Raise

September 27th, 2021 - Ryan Allway

Funds Earmarked for Growth Initiatives LAS VEGAS, Sept. 27, 2021 /CNW/ – Terry Booth, CEO, is pleased to announce – Australis Capital Inc., operating as AUDACIOUS (CSE: AUSA) (OTC: AUSAF) (“AUSA”, “AUDACIOUS”, or the “Company”), announced today that it has retained DelMorgan & Co., an internationally recognized investment banking firm, to assist AUDACIOUS with its $15 million capital raise.   Terry Booth, AUSA […]

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

September 10th, 2021 - Ryan Allway

The investment provides CaaMTech with capital to advance compounds from its library into clinical trials   ISSAQUAH, Wash., Sept. 08, 2021 (GLOBE NEWSWIRE) — CaaMTech, Inc., a leading psychedelic drug discovery company, has today announced the completion of a $22 million Series A financing round, led by Noetic Fund. The oversubscribed round of funding will be […]

Aleafia Health Announces Closing of $10 Million Credit Facility

August 23rd, 2021 - Ryan Allway

Credit Facility provides financial capacity to pursue accretive growth opportunities New debt lender increases financial flexibility with new source of capital Improves liquidity by growing cash and marketable securities balance to $25 million TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a leader in […]

Brains Bioceutical Corp. completes a USD $31.9 Million Capital Raise with Lead Investor DSM Venturing

June 17th, 2021 - Ryan Allway

VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (“Brains” or the “Company”) is pleased to announce the completion of a USD $31.9 million capital raise with DSM Venturing and existing Brains shareholders. DSM Venturing, who acted as lead investor in this round, is the corporate venture arm of Royal DSM (“DSM”), […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading